Cargando…

Cardiopulmonary bypass using heparin surface treatment: influence on memory and neurological deviations

Detalles Bibliográficos
Autores principales:	Svenmarker, S, Sandström, E, Karlsson, T, Häggmark, S, Jansson, E, Appelblad, M, Lindholm, R, Åberg, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300222/ http://dx.doi.org/10.1186/cc678

Ejemplares similares

Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
por: Mirow, N, et al.
Publicado: (2001)

Neurological damage due to coagulation and fat release during cardiopulmonary bypass
por: van Oeveren, Willem
Publicado: (2000)

Is the precise control of circulating heparin levels during cardiopulmonary bypass beneficial in paediatric open-heart surgery?
por: Codispoti, M, et al.
Publicado: (1999)

Cardiopulmonary resuscitation with cardiopulmonary bypass after cardiac surgery
por: Rodrigus, I, et al.
Publicado: (2000)

Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
por: Parissis, Haralabos
Publicado: (2011)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Is there a capillary leak after cardiopulmonary bypass in pigs?
por: Eising, GP, et al.
Publicado: (1999)

Metabolic acidosis and cardiopulmonary bypass: hypoperfusion or iatrogenic?
por: Cormack, LG, et al.
Publicado: (2002)

Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
por: Chen, Yufan, et al.
Publicado: (2022)

Acute phase response following cardiopulmonary bypass: impact of corticoid therapy
por: Ebert, E, et al.
Publicado: (1999)

Cardiopulmonary bypass and pulmonary surfactant: influence on composition and function?
por: Thul, J, et al.
Publicado: (2003)

Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial efficiency
por: Geissler, HJ, et al.
Publicado: (1999)

Postoperative complications following cardiac surgery with cardiopulmonary bypass
por: Atwell, DM, et al.
Publicado: (1997)

Cardiopulmonary Bypass Surgery in a Patient with Unexpected Heparin-Induced Thrombocytopenia
por: Miyagawa, Atsushi, et al.
Publicado: (2022)

How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass
por: Revelly, Etienne, et al.
Publicado: (2023)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Impact of cardiopulmonary-bypass assisted surgery on markers of monocyte function
por: Neuhaus, K, et al.
Publicado: (1999)

Hyperdynamic circulation following cardiopulmonary bypass predisposes to postoperative bleeding
por: Taneja, R, et al.
Publicado: (2001)

Postoperative morbidity following cardiopulmonary bypass may be attributed to endotoxemia
por: Walker, PM, et al.
Publicado: (1998)

Implantation of HIA-Medos system in children with and without cardiopulmonary bypass
por: Reiss, N, et al.
Publicado: (2001)

Cerebral cytokine expression after cardiac surgery with cardiopulmonary bypass
por: Qing, Ma, et al.
Publicado: (2003)

Aprotinin does not influence the inflammatory reaction to cardiopulmonary bypass in humans
por: Schmartz, D, et al.
Publicado: (1999)

Propranolol kinetics in patients submitted to cardiac surgery with cardiopulmonary bypass
por: Carmona, MJC, et al.
Publicado: (2001)

Heart failure impairs vasomotor functions of the mesenteric bed after cardiopulmonary bypass
por: Szabó, G, et al.
Publicado: (2001)

Neuropsychologic dysfunction after CABG: standard cardiopulmonary bypass versus off-pump CABG
por: Oudenaarde, I, et al.
Publicado: (2000)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

Pulmonary perfusion reduces accumulation of neutrophils in the lung during cardiopulmonary bypass
por: Schlensak, C, et al.
Publicado: (2003)

Increased apoptosis of circulating leukocytes during cardiac surgery with cardiopulmonary bypass
por: Hambsch, J, et al.
Publicado: (2003)

Evaluation of myocardial cell damage in cardiac lymph during cardiopulmonary bypass
por: Vazquez-Jimenez, JF, et al.
Publicado: (1999)

Progesterone and interleukin-8 during and after cardiopulmonary bypass in infants and children
por: Trotter, A, et al.
Publicado: (1999)

Depth of Anaesthesia Associated with 2.5% Isoflurane During Cardiopulmonary Bypass
por: Connelly, Michael D, et al.
Publicado: (2015)

Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery
por: Jia, Zaishen, et al.
Publicado: (2015)

Coagulation and neonatal bypass: an assessment of changes in coagulation factor concentration during cardiopulmonary bypass in neonates, with modified ultrafiltration
por: Arnold, P, et al.
Publicado: (1999)

Corticosteroids reduce neuron-specific-enolase liberation after cardiopulmonary bypass in men
por: Schmartz, D, et al.
Publicado: (2000)

Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
por: Joashi, U, et al.
Publicado: (2001)

Prediction of outcome in patients undergoing cardiac surgery on cardiopulmonary bypass using procalcitonin
por: Dörge, H, et al.
Publicado: (1999)

Retrograde autologous priming of the cardiopulmonary bypass circuit - effective and safe blood conservation
por: Balachandran, S, et al.
Publicado: (2001)

Jugular bulb desaturation during rewarming from cardiopulmonary bypass is influenced by isoflurane
por: Robson, MJA, et al.
Publicado: (1999)

Neurologic complications after cardiopulmonary bypass – A narrative review
por: Gilbey, Tom, et al.
Publicado: (2022)

Earlier extubation using axillary temperature as the endpoint for rewarming following hypothermic cardiopulmonary bypass
por: Kai, MA, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_fv6b36s2jjmkmui32qvgnklo6n